HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
26 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NR0B1
nuclear receptor subfamily 0 group B member 1
Chromosome X Β· Xp21.2
NCBI Gene: 190Ensembl: ENSG00000169297.8HGNC: HGNC:7960UniProt: F1D8P4
167PubMed Papers
22Diseases
0Drugs
128Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedReceptorTranscription Factor
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
negative regulation of steroid biosynthetic processnegative regulation of intracellular steroid hormone receptor signaling pathwaynegative regulation of gluconeogenesisnegative regulation of DNA-templated transcriptionCytomegalic congenital adrenal hypoplasiaX-linked adrenal hypoplasia congenita46,XY complete gonadal dysgenesis46,XY partial gonadal dysgenesis
✦AI Summary

NR0B1 encodes DAX-1, an orphan nuclear receptor that functions as a transcriptional corepressor lacking a DNA-binding domain 1. DAX-1 inhibits transcriptional activity of other nuclear receptors through heterodimeric interactions and is essential for hypothalamic-pituitary-adrenal-gonadal axis development 1. The protein can repress transcriptional activators through direct protein-protein interactions and bind DNA hairpin structures 2. Loss of NR0B1 function causes X-linked adrenal hypoplasia congenita (AHC), characterized by primary adrenal insufficiency presenting in infancy with salt-wasting and failure to thrive, followed by hypogonadotropic hypogonadism at puberty and impaired spermatogenesis 13. Clinical presentations are heterogeneous, including isolated mineralocorticoid insufficiency and precocious sexual development 34. NR0B1 mutations account for approximately 20% of congenital idiopathic hypogonadotropic hypogonadism cases 5. Duplication of the NR0B1 region causes dosage-sensitive sex reversal, with DAX-1 and the testis-determining factor Sry acting antagonistically in sex determination 2. Male patients carrying DAX-1 mutations frequently exhibit azoospermia, though assisted reproductive techniques may offer fertility options 6. Genetic testing is critical for accurate diagnosis and appropriate endocrine management.

Sources cited
1
NR0B1/DAX-1 function as nuclear receptors in adrenal and reproductive development; loss causes adrenal insufficiency, hypogonadotropic hypogonadism, and impaired spermatogenesis
PMID: 26303087
2
DAX-1 mutations associated with variable phenotypes including isolated mineralocorticoid insufficiency, precocious sexual development, and primary adrenal insufficiency
PMID: 21164257
3
DAX-1 acts as transcriptional repressor through protein-protein interactions and DNA hairpin binding; antagonistic relationship with Sry in sex determination
PMID: 10412368
4
NR0B1 gene mutations cause X-linked adrenal hypoplasia congenita with salt-wasting, cortisol deficiency, and precocious sexual development in infancy
PMID: 19508677
5
DAX1 mutations account for less than 20% of congenital idiopathic hypogonadotropic hypogonadism cases
PMID: 11079449
6
Male patients with DAX-1/NR0B1 mutations frequently present with azoospermia; TESE-ICSI may offer fertility options
PMID: 24751136
Disease Associationsβ“˜22
Cytomegalic congenital adrenal hypoplasiaOpen Targets
0.81Strong
X-linked adrenal hypoplasia congenitaOpen Targets
0.79Strong
46,XY complete gonadal dysgenesisOpen Targets
0.75Strong
46,XY partial gonadal dysgenesisOpen Targets
0.55Moderate
46,XX testicular disorder of sex developmentOpen Targets
0.55Moderate
neurodegenerative diseaseOpen Targets
0.48Moderate
alternating hemiplegia of childhoodOpen Targets
0.47Moderate
genetic disorderOpen Targets
0.19Weak
azoospermiaOpen Targets
0.09Suggestive
hepatocellular carcinomaOpen Targets
0.09Suggestive
lung adenocarcinomaOpen Targets
0.08Suggestive
prostate cancerOpen Targets
0.08Suggestive
46,XY disorder of sex development due to isolated 17,20 lyase deficiencyOpen Targets
0.08Suggestive
46,XX ovotesticular disorder of sex developmentOpen Targets
0.08Suggestive
cervical cancerOpen Targets
0.08Suggestive
Testicular regression syndromeOpen Targets
0.07Suggestive
46,XY disorder of sex development due to 5-alpha-reductase 2 deficiencyOpen Targets
0.07Suggestive
isochromosomy YpOpen Targets
0.07Suggestive
Ewing sarcomaOpen Targets
0.07Suggestive
Kallmann syndromeOpen Targets
0.07Suggestive
46,XY sex reversal 2UniProt
Adrenal hypoplasia, congenitalUniProt
Pathogenic Variants128
NM_000475.5(NR0B1):c.1273A>G (p.Arg425Gly)Pathogenic
NR0B1-related disorder|Congenital adrenal hypoplasia, X-linked|Differences in sex development
β˜…β˜…β˜†β˜†2025β†’ Residue 425
NM_000475.5(NR0B1):c.754C>T (p.Gln252Ter)Pathogenic
not provided|Congenital adrenal hypoplasia, X-linked
β˜…β˜…β˜†β˜†2025β†’ Residue 252
NM_000475.5(NR0B1):c.1411T>C (p.Ter471Gln)Likely pathogenic
Congenital adrenal hypoplasia, X-linked|Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2
β˜…β˜…β˜†β˜†2024β†’ Residue 471
NM_000475.5(NR0B1):c.516G>A (p.Trp172Ter)Pathogenic
46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked|Congenital adrenal hypoplasia, X-linked|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 172
NM_000475.5(NR0B1):c.551_552del (p.Lys184fs)Pathogenic
Congenital adrenal hypoplasia, X-linked|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 184
NM_000475.5(NR0B1):c.986_987delinsA (p.Gly329fs)Pathogenic
not provided|Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2
β˜…β˜…β˜†β˜†2024β†’ Residue 329
NM_000475.5(NR0B1):c.501del (p.Gly169fs)Pathogenic
Congenital adrenal hypoplasia, X-linked|NR0B1-related disorder|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked
β˜…β˜…β˜†β˜†2024β†’ Residue 169
NM_000475.5(NR0B1):c.919G>T (p.Glu307Ter)Pathogenic
Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked
β˜…β˜…β˜†β˜†2023β†’ Residue 307
NM_000475.5(NR0B1):c.1168+1_1168+20delPathogenic
Congenital adrenal hypoplasia, X-linked|Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2
β˜…β˜…β˜†β˜†2022
NM_000475.5(NR0B1):c.800G>C (p.Arg267Pro)Pathogenic
Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked
β˜…β˜…β˜†β˜†2021β†’ Residue 267
NM_000475.5(NR0B1):c.327C>A (p.Cys109Ter)Pathogenic
Congenital adrenal hypoplasia, X-linked|Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2
β˜…β˜…β˜†β˜†2021β†’ Residue 109
NM_000475.5(NR0B1):c.708G>A (p.Trp236Ter)Pathogenic
not provided|Congenital adrenal hypoplasia, X-linked|Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2
β˜…β˜…β˜†β˜†2018β†’ Residue 236
NM_000475.5(NR0B1):c.1141C>T (p.Leu381Phe)Pathogenic
Congenital adrenal hypoplasia, X-linked
β˜…β˜…β˜†β˜†2017β†’ Residue 381
NM_000475.5(NR0B1):c.1134C>A (p.Tyr378Ter)Pathogenic
Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2
β˜…β˜†β˜†β˜†2025β†’ Residue 378
NM_000475.5(NR0B1):c.339del (p.Val115fs)Pathogenic
Congenital adrenal hypoplasia, X-linked
β˜…β˜†β˜†β˜†2025β†’ Residue 115
NM_000475.5(NR0B1):c.399del (p.Cys135fs)Pathogenic
Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2
β˜…β˜†β˜†β˜†2025β†’ Residue 135
NM_000475.5(NR0B1):c.1292del (p.Ser431fs)Pathogenic
Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2
β˜…β˜†β˜†β˜†2025β†’ Residue 431
NM_000475.5(NR0B1):c.184dup (p.Leu62fs)Pathogenic
Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2
β˜…β˜†β˜†β˜†2024β†’ Residue 62
NM_000475.5(NR0B1):c.1037_1038insA (p.Ala347fs)Pathogenic
46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked
β˜…β˜†β˜†β˜†2024β†’ Residue 347
NM_000475.5(NR0B1):c.1099_1100insT (p.Lys367fs)Pathogenic
46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked
β˜…β˜†β˜†β˜†2024β†’ Residue 367
View on ClinVar β†—
Related Genes
NANOGProtein interaction100%RPS23Protein interaction100%RPL39Protein interaction100%RPL38Protein interaction100%RPL36AProtein interaction100%RPL32Protein interaction100%
Tissue Expression6 tissues
Ovary
100%
Brain
43%
Bone Marrow
2%
Liver
1%
Heart
0%
Lung
0%
Gene Interaction Network
Click a node to explore
NR0B1NANOGRPS23RPL39RPL38RPL36ARPL32
PROTEIN STRUCTURE
Preparing viewer…
PDB4RWV Β· 1.86 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.34Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.13 [0.06–0.34]
RankingsWhere NR0B1 stands among ~20K protein-coding genes
  • #2,673of 20,598
    Most Researched167 Β· top quartile
  • #606of 5,498
    Most Pathogenic Variants128 Β· top quartile
  • #1,438of 17,882
    Most Constrained (LOEUF)0.34 Β· top 10%
Genes detectedNR0B1
Sources retrieved26 papers
Response timeβ€”
πŸ“„ Sources
26β–Ό
1
DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease.
PMID: 26303087
Best Pract Res Clin Endocrinol Metab Β· 2015
1.00
2
Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function.
PMID: 21164257
Endocr Dev Β· 2011
0.90
3
[DAX-1 abnormality].
PMID: 11857932
Nihon Rinsho Β· 2002
0.80
4
Inhibition of Ξ²-catenin dependent WNT signalling upregulates the transcriptional repressor NR0B1 and downregulates markers of an A9 phenotype in human embryonic stem cell-derived dopaminergic neurons: Implications for Parkinson's disease.
PMID: 34941945
PLoS One Β· 2021
0.76
5
Diagnosis and management of non-CAH 46,XX disorders/differences in sex development.
PMID: 38812815
Front Endocrinol (Lausanne) Β· 2024
0.72